David M. Goldstein, Chief Scientific Officer at Principia Biopharma Inc. (PRNB), sold 11,200 shares at $86.92 ($993K) on 2020-08-10, disclosed to the SEC on 2020-08-12.
Open-market sale of $993k PRNB by Chief Scientific Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $86.11 | 858 | $74K | 7.4% |
| 2 | $86.11 | 858 | $74K | 7.4% |
| 3 | $86.92 | 700 | $61K | 6.1% |
| 4 | $88.40 | 2,534 | $224K | 22.6% |
| 5 | $88.40 | 2,534 | $224K | 22.6% |
| 6 | $89.68 | 700 |
| $63K |
| 6.3% |
| 7 | $89.68 | 700 | $63K | 6.3% |
| 8 | $90.99 | 1,108 | $101K | 10.2% |
| 9 | $90.99 | 1,108 | $101K | 10.2% |
| 10 | $93.34 | 100 | $9K | 0.9% |
| Total | $88.67 avg | 11,200 | $993K | 100% |
| Filing → |